This is your chance to learn directly from industry leaders at Allogene, Genentech, NKILT, ImmuneBridge, and more as they reveal how they’re identifying ‘super donors’ and using advanced assays to boost product consistency and performance. Walk away with proven strategies to reduce variability, de-risk manufacturing, and strengthen your allogeneic pipeline from the start.
Whether you're starting to build a donor screening program or scaling up an existing strategy, this is the only event dedicated to donor-derived material. We’re bringing together experts from academia, analytical development, supply chain, cryopreservation, and C-level executives to present practical, cross-functional takeaways you can apply immediately to accelerate timelines, cut costs, and meet clinical demand.
Why Attend in 2025?
2
Days of unmissable content, including new data & actionable insights from from allogeneic leaders
8+
Hours of networking & interactive discussion-led sessions to develop critical solutions to the most pressing challenges
14
Brand-new speakers across analytical development, supply chain, logistics, cryopreservation, and R&D teams
Don't Miss the Opportunity to:
Build Smarter Donor Strategies and Tackle Variability at the Source
Get practical, real-world insights from ImmuneBridge, Luminary Therapeutics, NKILT Therapeutics and more as they reveal how they’re screening, ranking, and retaining optimal donors. From computational analytics to new data on variability, you’ll walk away with actionable strategies to streamline donor selection, improve yield, and accelerate more scalable manufacturing.
Donor Profiles to Streamline Recruitment
What really defines a “super donor”? Join NKore BioTherapeutics and Genentech to explore intra-donor variability, and how lifestyle and motivation factors may be just as important as biomarkers. Challenge outdated assumptions and learn how building more inclusive, high-performing donor pools can reduce sourcing bottlenecks and make recruitment a smoother process.
Turn Donor Strategy into a Competitive Edge
Hear how Allogene and others are turning their donor strategy into a true value proposition. Whether you're looking to impress investors or scale with confidence, this is your chance to learn how smarter donor programs can give you the leading edge.
Safeguard Material Quality with Smarter Supply Chain Solutions
Learn how Genentech and Bristol Myers Squibb are tackling long-term donor access and reducing batch failures by advancing recallability, cryopreservation, and other logistics strategies. Leave with practical tools to protect consistency and keep your operations moving as you scale.
Who is Attending?
I felt that this was a very unique meeting where suppliers and consumers of blood products finally got in the same room to talk about the challenges and potential solutions to creating stable sources of apheresis units for allogeneic products"
Senior Director - Chemistry, Manufacturing & Controls, Regulatory Affairs, Imugene - Past Attendee